Cargando…

Seven-year exclusivity and beyond for drugs of rare diseases in China

Detalles Bibliográficos
Autores principales: Jiang, Yale, Huang, Huiyao, Zhao, Guo, Ma, Peiwen, Zhang, Liang, Wang, Shuhang, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600485/
https://www.ncbi.nlm.nih.gov/pubmed/37900168
http://dx.doi.org/10.3389/fphar.2023.1223056
_version_ 1785125997019922432
author Jiang, Yale
Huang, Huiyao
Zhao, Guo
Ma, Peiwen
Zhang, Liang
Wang, Shuhang
Li, Ning
author_facet Jiang, Yale
Huang, Huiyao
Zhao, Guo
Ma, Peiwen
Zhang, Liang
Wang, Shuhang
Li, Ning
author_sort Jiang, Yale
collection PubMed
description
format Online
Article
Text
id pubmed-10600485
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106004852023-10-27 Seven-year exclusivity and beyond for drugs of rare diseases in China Jiang, Yale Huang, Huiyao Zhao, Guo Ma, Peiwen Zhang, Liang Wang, Shuhang Li, Ning Front Pharmacol Pharmacology Frontiers Media S.A. 2023-10-12 /pmc/articles/PMC10600485/ /pubmed/37900168 http://dx.doi.org/10.3389/fphar.2023.1223056 Text en Copyright © 2023 Jiang, Huang, Zhao, Ma, Zhang, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Jiang, Yale
Huang, Huiyao
Zhao, Guo
Ma, Peiwen
Zhang, Liang
Wang, Shuhang
Li, Ning
Seven-year exclusivity and beyond for drugs of rare diseases in China
title Seven-year exclusivity and beyond for drugs of rare diseases in China
title_full Seven-year exclusivity and beyond for drugs of rare diseases in China
title_fullStr Seven-year exclusivity and beyond for drugs of rare diseases in China
title_full_unstemmed Seven-year exclusivity and beyond for drugs of rare diseases in China
title_short Seven-year exclusivity and beyond for drugs of rare diseases in China
title_sort seven-year exclusivity and beyond for drugs of rare diseases in china
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600485/
https://www.ncbi.nlm.nih.gov/pubmed/37900168
http://dx.doi.org/10.3389/fphar.2023.1223056
work_keys_str_mv AT jiangyale sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina
AT huanghuiyao sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina
AT zhaoguo sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina
AT mapeiwen sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina
AT zhangliang sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina
AT wangshuhang sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina
AT lining sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina